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Introduction 
   Significant advances in the field of biomedical instrumentation have continued to contribute 
towards improvements in the quality of clinical diagnosis and treatment, which could have 
important implications for health and welfare. Up to the present, progress in several topics has 
been reviewed within the “In the Spotlight” column, including new and noteworthy 
measurement methods [1], ballistocardiography revisited [2], wearable monitoring [3], and 
home healthcare technologies [4]. The present review deals with three notable topics from 
recent publications in the field of bioinstrumentation. These are: (1) new conducting polymer 
electrodes for in vivo bio-electrical measurements, (2) mHealth technology using mobile 
communication devices such as mobile phones and personal digital assistants (PDAs), and (3) 
non-invasive in vivo measurement of blood constituents. These topics are of recent or renewed 
interest and, where appropriate, progress since the previous reviews [1], [2] will be highlighted.   
 Conducting polymer electrodes for in vivo bio-electrical measurements 
   The design of electrodes coated with an appropriate conductive polymer to achieve 
long-term stability of in vivo bio-electrical measurements has been the focus of effort for a 
considerable time. Ongoing studies have been bringing some success, for example that Green et 
al. have recently demonstrated good stability of their electrodes, which are coated by 
poly-ethylene dioxythiophene doped with paratoluene sulfonate [5]. In the studies by these 
authors the electrodes were immersed in high serum content cell culture medium and were 
subjected to continuous electrical stimulation. They performed well, showing stable electrode 
characteristics during 1.3 billion pulses of stimulation. 
   In addition to the use of polymer-coated metal electrodes, there have been continuing 
interesting efforts to fabricate entire electrodes from conducting polymers. This type of 
conducting polymer electrode can be fabricated, for example, by chemical deposition methods 
and/or printing procedures usually used in the laboratory-based experimental production of 
biosensors [6], [7]. Conducting polymer electrodes fabricated in this way have become more 
sophisticated, enabling them to be used successfully for in vivo measurements [8]. Strongpoints 
of this electrode design as compared with a conventional electrode are (i) high flexibility, (ii) 
thin, (iii) lightweight, as well as (iv) long-term stability due to its material property [7-9].  
   Khodagholy et al. have described a very small, thin, and highly conformable electrode-array, 
fabricated using a photolithographic process. The electrode-array was found to have appropriate 
properties to yield in vivo recording of the electrocorticogram with a high SN ratio in rats [10]. 
The use of a conducting polymer (CP)-modified electrode in small animals has also been 
reported by Forcelli et al. [11] By comparison with the conventionally used platinum electrode, 
their CP-modified electrode showed a significant decrease in anomalous reaction of astrocytes, 
detecting intracranial electroencephalographic signals measured with a high SN ratio. 
   In addition to their use for biopotential recording there are noteworthy applications of 
conducting polymers in other areas, including in biosensors. Rahman et al. have demonstrated a 
superoxide anion radical micro-biosensor with enhanced stability and sensitivity, fabricated by 
the sequential immobilization of lipid and cytochrome c that were covalently bonded onto a 
conducting polymer layer. This micro-biosensor was implanted into a rat brain to determine 
successfully the extracellular level of the superoxide anion radical induced by acute and 
repeated injections of cocaine [12].  
Taking the advantageous mechanical and electrical properties of greater flexibility, thinner, 
more lightweight devices, and long-term stability into consideration, the conducting polymer 
electrode appears promising for wide-ranging bioelectrical measurements. However, further 
research in terms of safety and efficacy for much longer-term use will be necessary for human 
applications. 
 
Recent advances in mHealth and mobile bioinstrumentation 
mHealth (also written as m-health or mobile health) is a part of eHealth (electronic health) 
and is the provision of health services and information by using mobile communication devices 
such as mobile phones and PDAs. Applications include collection of clinical health data, 
delivery of healthcare information to practitioners, researchers and patients, as well as handy 
bioinstrumentation for real-time monitoring of patient vital signs, and direct provision of care 
via mobile telemedicine [13]. The mHealth field could also make key contributions to 
point-of-care testing (POCT), which is now of widespread interest as a component of emerging 
clinical medicine [14]. Rapid advances in the field of mHealth strongly depend on significant 
recent progress in information and communication technology (ICT), which of course includes 
mobile communication technologies. 
   Historically, the basic concept of mHealth was first described relatively recently, one of the 
first approaches for medical diagnosis being reported by Martinez et al. in 2008 [15]. They 
proposed a system consisting of paper-based microfluidic devices for multiple assays and 
camera phones for digitizing the colorimetric information to transfer the results. Granot et al. 
reported a quite different application in which the cellular phone is used with associated 
instrumentation for medical imaging based on electrical impedance tomography [16].  
   Details of current progress in mHealth have been reviewed by Kyriacou et al. [17] and 
Boulos et al. [18]. Among recent research publications on mHealth [19]-[28], one can see that 
the configuration for PDA-based instrumentation systems is categorized into two types, as 
shown in Fig. 1: Type-A (Fig. 1(a)) is to combine a PDA with external healthcare equipment 
[19]-[21], and type-B (Fig. 1(b)) is to use only a PDA which can measure medical images and 
physiological signals utilizing the built-in CCD camera and/or the camera flash as a light source 
[22]-[29]. Some noteworthy studies are introduced as follows. 
   The first description of a type-A system has very recently been reported by Huang et al. [19], 
who have developed a smartphone-based portable pulse-wave ultrasound Doppler blood 
flowmeter. Doppler shift signals obtained from a compact external circuit unit are led directly to 
the phone which processes and displays Doppler spectrograms corresponding to arterial blood 
flow. These authors successfully made in vivo measurements of blood flow in a rat, showing the 
potential for using a smartphone in portable medical ultrasound applications. Based on this 
concept, mobile phone-based diagnostic systems incorporating an external device have been 
reported to monitor such physiological variables as the ECG [20], respiration rate, cardiac R-R 
intervals and blood oxygen saturation [21]. The full potential of this approach to 
bioinstrumentation development will be reached when the necessary external medical 
equipment becomes more compact and capable of measuring the required variety of vital signs 
and sensor-derived data. Widespread medical applications are then anticipated. 
   In a different form of imaging Breslauer et al. [22] reported a mobile phone-mounted 
microscope for diagnostic imaging and telemedicine. They demonstrated the potential for 
clinical use by capturing and displaying images of falciparum-infected and sickle red blood 
cells and microorganism morphology using tuberculosis-infected sputum samples. Such uses 
point the way to mobile phone-based global healthcare for disease diagnosis and screening. 
Smith et al. [23] also presented a smartphone-based spectrometer with a transmission grating to 
obtain the transmission spectrum of a human finger-tip. 
   Although an extra unit attached to the phone is needed in the systems mentioned above, 
there have been several trials of system without any extra units using only a smartphone, 
defined above as type-B [24]-[29]. Among them, a system reported by Jonathan and Leahy for 
reflectance-type photoplethysmographic imaging from a finger-tip is particularly notable [24], 
[26]. With this approach the phone-embedded camera is used as a photo-sensor and the camera 
flash LED is used as the light source. Based on this technique, the monitoring and performance 
assessment of heart rate (HR) and/or HR variability determined by a mobile phone or 
smartphone have also been reported [25], [28]. Most recently, it is in particular noteworthy that 
a smartphone-based monitoring of HR together with normalized pulse volume, which is an 
index of finger vascular tone [29], has been newly developed [30] and now available for 
practical use [31].  
   In a feasibility study of a similar system described above a challenging attempt has been 
made to achieve non-contact multiparameter physiological measurement using a webcam to 
obtain HR, HR variability and respiration rate processed by color images of the human face [27]. 
Although the range of physiological quantities that can be obtained by type-B systems are 
significantly limited at present as compared to type-A, type-B is naturally the most desirable for 
medical applications, particularly as a convenient tool in point-of-care testing. 
   There can be little doubt that mobile bioinstrumentation using a smartphone or one of a 
variety of PDAs, which are commonly carried around nowadays in normal daily life, will 
become the ideal platform for data processing, storage and communication. In the 
not-too-distant future, one can foresee an innovative change from the conventional system 
configuration for ambulatory/wearable physiological measurement such as the Holter ECG 
recorder, ambulatory blood pressure monitor (ABPM), and so on. In this respect, the approach 
of using mobile-based bioinstrumentation has a significant potential for providing a much more 
convenient, compact and easier-to-use tool not only for medical diagnosis but also for general 
healthcare in normal daily living. 
 Further challenges in non-invasive optical measurement of blood constituents 
In the previous issues, an overview of the current status in non-invasive optical 
measurement of blood constituents was surveyed [1], [2]. This challenging topic remains even 
now a major interest worldwide, and thus in this Spotlight column the most recent developments 
since 2009 will be described. 
The background research upon which in vivo spectroscopic analysis is based necessarily 
requires a full understanding of the in vitro absorption spectra (ABS) of relevant test fluids. This 
work also includes determination of the sensitivity ratio (STR), representing the absorbance 
change with respect to the change in concentration of the solution in specified wavelength bands. 
Accurate in vitro measurements of ABS and STRs of solutions of such substances as glucose 
(GLU), human serum albumin (HSA) and ethyl alcohol (EAL) have been reported [32]-[34]. 
Unlike ABS of oxy- and deoxy-hemoglobin, the ABS changes in association with the 
concentration change in each substance are well known to be considerably small, and these 
reports clearly demonstrated ABS of each single and mixed solutions of GLU and HAS [32], 
[33] and that of EAL and mixed solutions of EAL, GLU and acetaldehyde in the range of 750 – 
2500 nm [34], together with very small but significantly discernible values of STRs at some 
specific wavelength regions. These findings provide useful and valuable information for 
quantifying concentrations of these blood constituents determined in vitro as well as possibly in 
vivo by optical techniques. 
   Despite the importance of in vivo blood constituent measurement there have been few 
definitive reports that represent significant and scientifically sound methodological advances in 
non-invasive techniques. Nevertheless, some reports concerning blood glucose [35]-[37] and 
alcohol measurements [38] are briefly introduced here.  
   There have been attempts to use electrical impedance spectroscopy for non-invasive blood 
glucose (BGL) monitoring, although trials revealed significant problems [39]. An interesting 
new multisensor method for non-invasive BGL measurement based on the combination of 
dielectric spectroscopy and optical reflectance spectroscopy has been reported [35], [36]. In this 
approach, measurements are made of impedance spectrogram together with reflected light 
intensity from the tissue, skin temperature, humidity surrounding the tissue and measuring site 
movement. In trials Clark error-grid analyses showed relatively good results. However, there are 
still some issues to be clarified before this multisensor approach is successful.  
   Monte-Moreno [37] has proposed a very interesting method based on machine learning 
techniques for the simultaneous estimation of BGL levels together with systolic and diastolic 
blood pressure from the waveform shape of the photoplethysmogram (PPG) measured in a 
finger. The theory is that there is functional relationship between the shape of the PPG 
waveform and the blood pressure and BGL levels. Very favorable results were obtained in a 
study on 410 volunteers, the machine learning techniques tested being: ridge linear regression; a 
multilayer perception neural network; support vector machines; and random forests. According 
to their study, the best results were obtained with the random forest technique. This approach 
appears attractive and will no doubt be examined further. 
   Very recently, for the purpose of developing an alcohol-based vehicle ignition-interlock 
device, the non-invasive quantification of blood alcohol concentration (BAC) using 
near-infrared (NIR) light has been proposed [38]. This method, named “pulse alcometry”, is 
based, firstly, on the evidence that ethyl alcohol has an absorption peak in the NIR region at 
1185 nm [34], and, secondly, on the principles used in “pulse oximetry” and the recently 
developed “pulse glucometry” for the non-invasive optical measurement of blood oxygen 
saturation and BGL levels respectively [40]. Using second derivative values of the absorbance 
changes calculated from transmittance photoplethysmographic pulsations in a finger measured 
with the close-set of 3 wavelengths (1150, 1185 and 1220 nm), a simple linear regression 
analysis was made to predict BAC levels, showing good agreements between the predicted and 
the measured BAC values obtained from blood sampling. Since this method appears to be an 
initial development, further investigations using a number of subjects will be needed in order to 
strengthen the method for the ultimate use as an alcohol-based ignition-interlock device. 
 Acknowledgement 
The author wishes to thank Dr Mitsuhiro Ogawa, Teikyo University, Japan, and Dr 
Takehiro Yamakoshi, Kanazawa University, Japan, for their elaborate efforts on assisting in the 
survey of publications relating to current topics. He is also very grateful to Professor Peter Rolfe, 
Harbin Institute of Technology, China, and OBH Ltd., UK., for his valuable comments as well 
as for his kind help in preparing the manuscript. 
 
References 
[1] K. Yamakoshi, “In the Spotlight: Bioinstrumentation,” IEEE Rev. Biomed. Eng., vol. 1, pp. 
2-3, 2008. 
[2] K. Yamakoshi, “In the Spotlight: Bioinstrumentation,” IEEE Rev. Biomed. Eng., vol. 2, pp. 
2-5, 2009. 
[3] K. Yamakoshi, “In the Spotlight: Bioinstrumentation,” IEEE Rev. Biomed. Eng., vol. 3, pp. 
3-6, 2010. 
[4] K. Yamakoshi, “In the Spotlight: Bioinstrumentation,” IEEE Rev. Biomed. Eng., vo4. 1, pp. 
6-8, 2011. 
[5] R. A. Green, R. T. Hassarati, L. Bouchinet, C. S. Lee, G. L. Cheong, J. F. Yu, C. W. Dodds, 
G. J. Suaning, L. A. Poole-Warren LA and N. H. Lovell, “Substrate dependent stability of 
conducting polymer coatings on medical electrodes,” Biomaterials, vol. 33, pp. 5875-86, 2012. 
[6] M. Gerard, A. Chaubey and B. D. Malhotra, “Application of conducting polymers to 
biosensors,” Biosens. Bioelectr., vol. 17, issue 5, pp. 345-359, 2002. 
[7] X. Cui, J. F. Hetke, J. A. Wiler, D. J. Anderson and D. C. Martin, “Electrochemical 
deposition and characterization of conducting polymer polypyrrole/PSS on multichannel neural 
probes,” Sens. Actuat. A: Physical, vol. 93, issue 1, pp. 8-18, 2001. 
[8] S. Sekine, Y. Ido, T. Miyake, K. Nagamine and M. Nishizawa, “Conducting polymer 
electrodes printed on hydrogel,” J. Am. Chem. Soc., vol. 132. no. 38, pp. 13174–13175, 2010. 
[9] R. J. Waltman and J. Bargon, “Electrically conducting polymers: a review of the 
electropolymerization reaction, of the effects of chemical structure on polymer film properties, 
and of applications towards technology,” Can. J. Chem., vol. 64, no. 1, pp. 76-95, 1986. 
[10] D. Khodagholy, T. Doublet, M. Gurfinkel, P. Quilichini, E. Ismailova, P. Leleux, T. Herve, 
S Sanaur, C. Bernard and G. G. Malliaras, “Highly Conformable Conducting Polymer 
Electrodes for In Vivo Recordings,” Adv. Mater., vol. 23, pp. H268–H272, 2011. 
[11] P. A. Forcelli, C. T. Sweeney, A. D. Kammerich, B. C.-W. Lee, L. H. Rubinson, Y. P. 
Kayinamura, K. Gale and J. F. Rubinson, “Histocompatibility and in vivo signal throughput for 
PEDOT, PEDOP, P3MT, and polycarbazole electrodes,” J. Biomed. Mater. Res. Part A, Article 
first published online: 20 JUL 2012, DOI: 10.1002/jbm.a.34285 
[12] M. A. Rahman, A. Kothalam, E. S. Choe, M.-S. Won and Y.-B. Shim, “Stability and 
Sensitivity Enhanced Electrochemical In Vivo Superoxide Microbiosensor Based on Covalently 
Co-immobilized Lipid and Cytochrome c,” Anal. Chem., vol. 84, pp. 6654-6660, 2012. 
[13] P. Cipresso, S. Serino, D. Villani, C. Repetto, L. Selitti, G. Albani, A. Mauro, A. Gaggioli 
and G. Riva, “Is your phone so smart to affect your states? An exploratory study based on 
psychophysiological measures,” Neurocomputing, vol. 84, pp. 23–30, 2012. 
[14] D. A. Anderson, S. M. Crowe and M. Garcia, “Point-of-care testing,” Curr. HIV/AIDS 
Rep., vol. 8, pp. 31-37, 2011. DOI 10.1007/s11904-010-0067-z 
[15] A. W. Martinez, S. T. Phillips, E. Carrilho, S. W. Thomas III, H. Sindi, and G. M. 
Whitesides, “Simple telemedicine for developing regions: Camera phones and paper-based 
microfluidic devices for real-time, off-site diagnosis,” Anal. Chem., vol. 80, pp. 3699-3707 
2008. 
[16] Y. Granot, A. Ivorra and B. Rubinsky, “A new concept for medical imaging centered on 
cellular phone technology,” PloS one, vol. 3, p.e2075, 2008. 
[17] E. C. Kyriacou, C. S. Pattichis and M. S. Pattichis, “An overview of recent health care 
support systems for eEmergency and mHealth applications,” in Proc. 31st Annu. Int. Conf. IEEE 
Eng. Med. Biol., 2009, pp. 1246-1249. 
[18] M. N. K. Boulos, S. Wheeler, C. Tavares and R. Jones, “How smartphones are changing 
the face of mobile and participatory healthcare: an overview, with example from eCAALYX,” 
BioMed. Eng. OnLine, vol. 10, p. 24, 2011. 
[19] C. C. Huang, P. Y. Lee, P. Y. Chen and T. Y. Liu, “Design and implementation of a 
smartphone-based portable ultrasound pulsed-wave Doppler device for blood flow 
measurement,” IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 59, pp. 182-8, 2012. 
[20] D. H. Lee, A. Rabbi, J. Choi and R. Fazal-Rezai, “Development of a mobile phone based 
e-Health monitoring application,” Int. J. Adv. Comput. Sci. Applicat., vol. 3, pp. 38-43, 2012. 
[21] C. G. Scully, J. Lee, J. Meyer, A. M. Gorbach, D. Granquist-Fraser, Y. Mendelson and K. 
H. Chon, “Physiological parameter monitoring from optical recordings with a mobile phone,” 
IEEE Trans. Biomed. Eng., vol. 59, pp. 303-6, 2012. 
[22] D. N. Breslauer, R. N. Maamari, N. A. Switz, W. A. Lam and D. A. Fletcher, “Mobile 
Phone Based Clinical Microscopy for Global Health Applications,” PloS one, vol. 4, e6320, 
2009. 
[23] Z. J. Smith, K. Chu, A. R. Espenson, M. Rahimzadeh, A. Gryshuk, M. Molinaro, D. M. 
Dwyre, S. Lane, D. Matthews and S. Wachsmann-Hogiu, “Cell-Phone-Based Platform for 
Biomedical Device Development and Education Applications,” PloS one, vol. 6, e17150, 2011. 
[24] E. Jonathan and M. Leahy, "Investigating a smartphone imaging unit for 
photoplethysmography," Physiol. Meas., vol. 31, pp. 79-83, 2010. 
[25] P. Pelegris, K. Banitsas, T. Orbach and K. Marias, “A novel method to detect Heart Beat 
Rate using a mobile phone,” in Proc. 32nd Annu. Int. Conf. IEEE Eng. Med. Biol., 2010, pp. 
5488-5491. 
[26] E. Jonathan and M. J. Leahy, “Cellular phone-based photoplethysmographic imaging,” J. 
Biophotonics, vol. 4, pp.293-6, 2011. 
[27] M. Z. Poh, D. J. McDuff and R. W. Picard, “Advancements in noncontact, multiparameter 
physiological measurements using a webcam,” IEEE Trans. Biomed. Eng., vol. 58, pp. 7-11, 
2011. 
[28] J. B. Bolkhovsky, C. G. Scully and K. H. Chon, “Statistical analysis of heart rate and heart 
rate variability monitoring through the use of smart phone cameras,” in Proc. 34th Annu. Int. 
Conf. IEEE Eng. Med. Biol., 2012, pp. 1610-1613. 
 [29] Y. Sawada, G. Tanaka, and K. Yamakoshi, “Normalized pulse volume (NPV) derived 
photo-plethysmographically as a more valid measure of the finger vascular tone,” Int. J. 
Psychophysiol., vol. 41, no. 1, pp. 1-10, 2001. 
[30] K. Matsumura and T. Yamakoshi,”iPhysioMeter: A new approach for measuring heart rate 
and normalized pulse volume using a smartphone,” Behav. Res. Methods, vol. 44, no. 4, 2013, 
DOI 10.3758/s13428-012-0312-z. 
[31] K. Matsumura and T. Yamakoshi. iPhysioMeter.com, Measuring Your Physiological 
Indices Using Only an iPhone, 2012. Available: http://iphysiometer.com/app/ 
[32] M. Ogawa, T. Yamakoshi, Y. Yamakohsi and K. Yamakoshi, “Determination of concentrations 
of human serum albumin in phosphate buffer solutions using near-infrared spectroscopy in the 
region of 750-2500 nm,” Internet J. Bioeng., vol. 4, no. 2, 2010. 
[33] M. Ogawa, T. Yamakoshi, K. Motoi, K. Nishida, Y. Yamakoshi and K. Yamakoshi, 
“Determination of concentrations of glucose and human serum albumin in mixtures in 
phosphate buffered solution by near-infrared spectroscopy,” Sens. Mater., vol. 24, no. 6, pp. 
323-333, 2012. 
[34] T. Yamakoshi, M. Ogawa, K. Matsumura, S. Miyazaki, Y. Itasaka, T. Ida, Y. Yamakoshi, 
H. Hirose and K. Yamakoshi, “Towards non-invasive optical blood alcohol measurement: 
Multi-variate analysis of in vitro NIR spectra,” IEEJ Trans. Electron. Inform. Sys., vol. 132, no. 
12, 2012. (in press) 
[35] A. Caduff, M. Mueller, A. Megej, F. Dewarrat, R. E. Suri, J. Klisic, M. Donath, P. 
Zakharov, D. Schaub, W. A. Stahel and M. S. Talary, “Characteristics of a multisensor system 
for non invasive glucose monitoring with external validation and prospective evaluation,” 
Biosens. Bioelectron., vol. 26, issue 9, pp. 3794-3800, 2011. 
[36] M. Zanon, G. Sparacino, A. Facchinetti, M. Riz, M. S. Talary, R. E. Suri, A. Caduff and C. 
Cobelli, “Non-invasive continuous glucose monitoring: improved accuracy of point and trend 
estimates of the multisensor system,” Med. Biol. Eng. Comput., 2012, DOI 
10.1007/s11517-012-0932-6, (Epub ahead of print) 
[37] E. Monte-Moreno, “Non-invasive estimate of blood glucose and blood pressure from a 
photoplethysmograph by means of machine learning techniques,” Artif. Intell. Med., vol. 53, pp. 
127-138, 2011. 
[38] T. Yamakoshi, M. Ogawa, K. Matsumura, Y. Itasaka, S. Miyazaki, Y. Yamakoshi, P. Rolfe, 
H. Hirose and K. Yamakoshi, “A preliminary study on development of a novel optical 
instrument for non-invasive blood alcohol measurement: Proposal of pulse alcometry,” Trans. 
Jpn. Soc. Med. Biol. Eng., vol. 50, no. 2, pp. 237-247, 2012. 
[39] I. M. E. Wentholt, J. B. L. Hoekstra, A. Zwart and J. H. DeVries, “Pendra goes Dutch: 
lessons for the CE mark in Europe,” Diabetologia, vol. 48, no. 6, pp. 1055-1058, DOI: 10.1007/ 
s00125-005-1754-y, 2005. 
[40] K. Yamakoshi and Y. Yamakoshi, “Pulse glucometry: a new approach for noninvasive 
blood glucose measurement using instantaneous differential near-infrared spectrophotometry,” J. 
Biomed. Opt., vol. 11, 054028(1-9), 2006. 
(Fig. 1: K. Yamakoshi) 
 
Figure Legend 
Fig. 1: Configuration for the PDA-based instrumentation systems: (a) shows type-A, that is to 
combine a PDA (smartphone in this figure) with an external healthcare equipment such as a 
sphygmomanometer, ear sensors for pulse rate and temperature measurements, and so on, while 
(b) indicates type-B, that is to use only a PDA. See text for further explanation. 
 
